Type 2 Diabetes

Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a research study evaluating an investigational oral medication targeting cortisol-related metabolic dysfunction. 

Age Range: 18
Gender: Male and Female
Location: Media, Pennsylvania

About the Study

This research study is evaluating an investigational medication called clofutriben, which works by inhibiting an enzyme involved in cortisol regulation. By reducing the effects of excess cortisol, this therapy may help improve blood sugar control and overall metabolic health.  

The purpose of this study is to better understand how well this medication works compared to placebo (inactive treatment), and to evaluate its safety in people with type 2 diabetes and elevated cortisol levels.  

Qualifications

Qualifications 

You may be able to join if you: 

  • Are 18 years of age or older 
  • Have type 2 diabetes for at least 1 year 
  • Have an HbA1c (blood sugar level) of 7.5% or higher 
  • Are currently taking at least two diabetes medications at stable doses 
  • Have difficulty achieving blood sugar control despite treatment 
  • Are willing and able to attend study visits and follow study procedures  

If you’re interested in participating or want to learn more, contact us today to see if you may qualify. 

FEATURED STUDIES

Scroll to Top

Volunteer for this Study